TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive NIH Seeks Method For Allocating Research Funds, Determine Economic Impact By Disease Category April 26, 1974